dexamethasone, Hepion

Remember President Trump Taking Dexamethasone? Hepion’s (HEPA) CRV431 demonstrated reduced lung inflammation and damage...

Hepion (HEPA) Announces FDA Clearance of IND Application for CRV431 for COVID-19

Does Co-Diagnostics (CODX) Have Ties to Offshore Boiler Rooms?

Hot Covid-19 test company has ties to offshore boiler rooms (SharesSleuth.com) AKA, you'd have to have your head examined...
citius pharma, biotech stock review

Investors Bet $8 Million on Citius Pharma (CTXR) $1.10, Succeeding in FDA Trials!

Great headline, right? The actual headline was: Citius Pharmaceuticals Increases Previously Announced Bought Deal Offering to $8.4 Million
Alpex BioCleanse, Biotech Stock Review

Our Favorite Hand Sanitizer Company, Aphex BioCleanse Systems Inc., is Now Publicly Traded!

Sunset Capital Assets, Inc., (SNST), Executes and Completes Definitive Share Exchange Agreement with Aphex BioCleanse Systems Inc. Our favorite...

2020 Biotech Portfolio Soars 55%, We’re Amazed. Next Up: The Coming Gold Rush.

1. Yep, We Are Absolutely Amazed At The Biotech Stock Review's 2020 Watch List Performance – Especially In The Light Of...

SEC Charges Microcap Fraud Scheme Participants Attempting to Capitalize on the COVID-19 Pandemic.

FOR IMMEDIATE RELEASE2020-131 Washington D.C., June 11, 2020 — The Securities and...
Immuron, Biotech Stock Review

Immuron (IMRN) to Bank $20 Million.

Another Corona Virus Mania Makes Bank. This time $20 million into Immuron which once struggled, when it was trading near $2.00 just...

And Just Like That, We Have Another Double. iBio (IBIO).

$5.35 With 11 Million Shares Traded and it's Not Even 10:00!

Where is Citius Pharma (CTXR) in the FDA Approval Process?

We have a number of subscribers asking for an update on the FDA approval process for Mino-Lok. In layman's term (assuming approval)...

Latest article

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...

GeoVax (GOVX) Launches Vaccine Manufacturing System.

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System Manufacturing Process for Phase 3 and Commercial Production...